Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Matteo Scoletta"'
Autor:
Fulvio Ricceri, Paolo Vineis, P Matullo, Matteo Scoletta, Elisa Menegatti, Roberto Broccoletti, Paolo G. Arduino, Silvia Polidoro, Daniela Berardi, A. Comba
Publikováno v:
Oral Diseases. 18:3-10
Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: anin vitromodel
Autor:
Matteo Scoletta, Marina Maggiora, Libero Ciuffreda, Marco Mozzati, S. Saracino, Giuliana Muzio, Manuela Oraldi, Stefano Carossa, R. A. Canuto, A. M. Vandone
Publikováno v:
Journal of Oral Pathology & Medicine. 41:788-792
J Oral Pathol Med (2012) 41: 788–792 Background: Osteonecrosis of the jaw (ONJ) is a chronic complication of bisphosphonate therapy, mainly when intravenous, in cancer patients with bone metastases and myeloma. Its pathophysiology is not yet fully
Autor:
C Battaglio, Roberto Broccoletti, M Donadio, Paolo G. Arduino, Andrea Chiecchio, Daniela Berardi, A. M. Vandone, Crispian Scully, Matteo Scoletta, Marco Mozzati, Elisa Menegatti, Sergio Gandolfo
Publikováno v:
Journal of Oral Pathology & Medicine. 40:510-515
J Oral Pathol Med (2010) 40: 510–515 Objective: To investigate the polymorphisms of the vascular endothelial growth factor (VEGF) gene in relation to female patients who developed bisphosphonate-related osteonecrosis of the jaws (BRONJ). Methods: T
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 110:46-53
Objectives The aim of this study was to evaluate the 2-year success rate of management of patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ). Study design A prospective study was performed. Positive outcome variables were the reso
Autor:
Giovanni Lo Re, Giorgia Saia, Camillo Porta, Giordana Bettini, Vittorio Fusco, Riccardo Bonacina, Matteo Scoletta, Giuseppina Campisi, Chiara Paglino, Pamela Francesca Guglielmini, Elisabetta Merigo, Paolo Vescovi, Alberto Bedogni, Olga Di Fede
Osteonecrosis of the jaw (ONJ) associated with the use of bisphosphonates has been rarely reported in metastatic renal cell cancer (RCC) patients. Since the introduction of combined therapies consisting of nitrogen-containing bisphosphonates (NBPs) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb1d9d13c9abb7a9bf5fa7f655518ea
http://hdl.handle.net/11577/3156559
http://hdl.handle.net/11577/3156559
Autor:
Giorgia Gallesio, Andrea Chiecchio, Crispian Scully, Paolo G. Arduino, Valentina Arata, Ennio Lerda, Marco Mozzati, Matteo Scoletta
Purpose The aim of this prospective hospital-based study was to refine a surgical protocol for tooth extractions in patients with a history of intravenous use of a potent bisphosphonate by modifying a previously reported protocol to produce a signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4eea9fba70ddc3b927d55e5094ed8c
http://hdl.handle.net/2318/127577
http://hdl.handle.net/2318/127577
Autor:
Stefano Carossa, Giuliana Muzio, Marco Mozzati, Germana Martinasso, Matteo Scoletta, Manuela Oraldi, Marta Zambelli, Marina Maggiora, Rosa Angela Canuto
The intravenous injection of bisphosphonates, currently used as treatment for osteoporosis, bone Paget's disease, multiple myeloma, or bone metastases, can cause jaw bone necrosis especially in consequence of trauma. The present research aimed to cla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::978654125ce68effc38488c6c0660d33
http://hdl.handle.net/2318/120331
http://hdl.handle.net/2318/120331
Autor:
Giuseppe Matullo, Matteo Scoletta, Elisa Menegatti, Gianluca Campanella, Cornelia Di Gaetano, Crispian Scully, Silvia Polidoro, Paolo G. Arduino, Ennio Lerda, Daniela Berardi, Paolo Vineis, Roberto Broccoletti
Bisphosphonates are used in the treatment of hypocalcaemia, mainly in cancer and osteoporosis. Some patients experience adverse events, such as BP-related osteonecrosis of the jaw (BRONJ). DNA methylation plays a key role in gene regulation in many t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac9aa44f8ac7ea76615b9dcc5993dd8
http://hdl.handle.net/2318/139349
http://hdl.handle.net/2318/139349
Autor:
Mario Gabriele, Mario Miccoli, Stefano Gennai, Franco Peluso, Giuseppina Campisi, Filippo Graziani, Giovanni Maria Gaeta, Giuseppe Colella, Paolo Vescovi, Franco Goia, Gianfranco Favia, Matteo Scoletta, Luigi Solazzo
PURPOSE: The aim of this study was to evaluate the results of the surgical treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a large cohort. MATERIALS AND METHODS: A retrospective cohort multicenter study was designed. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbaa6cb91f3e074cd6a06a6dbff93bd4
http://hdl.handle.net/11568/157048
http://hdl.handle.net/11568/157048
Publikováno v:
Oral oncology. 48(5)
summary Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an important complication in cancer patients taking intravenous BPs (BPs). In most cases, BRONJ is associated with an oral surgery procedure involving jaw bone. Currently, BRONJ manag